W. Lofters

1.5k total citations
23 papers, 1.2k citations indexed

About

W. Lofters is a scholar working on Surgery, Immunology and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, W. Lofters has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Immunology and 7 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in W. Lofters's work include Nausea and vomiting management (8 papers), T-cell and Retrovirus Studies (7 papers) and Vector-Borne Animal Diseases (7 papers). W. Lofters is often cited by papers focused on Nausea and vomiting management (8 papers), T-cell and Retrovirus Studies (7 papers) and Vector-Borne Animal Diseases (7 papers). W. Lofters collaborates with scholars based in Canada, United States and Jamaica. W. Lofters's co-authors include W. N. Gibbs, B Hanchard, W. A. Blattner, James J. Goedert, Edward L. Murphy, J. Peter Figueroa, Benny Zee, Joseph L. Pater, B. Norris and Michael Palmer and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

W. Lofters

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Lofters Canada 14 455 435 348 313 280 23 1.2k
Tomoko Ohtsu Japan 16 198 0.4× 374 0.9× 84 0.2× 111 0.4× 32 0.1× 33 758
B Varet France 12 194 0.4× 227 0.5× 40 0.1× 42 0.1× 32 0.1× 46 874
Shigeyoshi Makino Japan 16 259 0.6× 199 0.5× 42 0.1× 45 0.1× 118 0.4× 106 936
Chiu‐Hwa Wang Taiwan 19 342 0.8× 349 0.8× 37 0.1× 35 0.1× 25 0.1× 39 1.1k
Jean Claude Brouet France 13 166 0.4× 221 0.5× 40 0.1× 42 0.1× 83 0.3× 16 836
Mikinori Miyazaki Japan 13 337 0.7× 375 0.9× 26 0.1× 42 0.1× 73 0.3× 32 889
T Ohnoshi Japan 14 100 0.2× 308 0.7× 22 0.1× 23 0.1× 68 0.2× 92 721
Suminori Akiba Japan 10 52 0.1× 302 0.7× 19 0.1× 27 0.1× 64 0.2× 16 613
G Sébahoun France 14 240 0.5× 151 0.3× 17 0.0× 17 0.1× 35 0.1× 61 585
Akitoshi Kinoshita Japan 19 119 0.3× 516 1.2× 8 0.0× 15 0.0× 96 0.3× 93 1.2k

Countries citing papers authored by W. Lofters

Since Specialization
Citations

This map shows the geographic impact of W. Lofters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Lofters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Lofters more than expected).

Fields of papers citing papers by W. Lofters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Lofters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Lofters. The network helps show where W. Lofters may publish in the future.

Co-authorship network of co-authors of W. Lofters

This figure shows the co-authorship network connecting the top 25 collaborators of W. Lofters. A scholar is included among the top collaborators of W. Lofters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Lofters. W. Lofters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Cripps, C., Margot J. Burnell, Jacques Jolivet, et al.. (1999). Phase II study of first-line LY231514 (multi-targeted antifolate) in patients with locally advanced or metastatic colorectal cancer: An NCIC Clinical Trials Group study. Annals of Oncology. 10(10). 1175–1179. 87 indexed citations
3.
Pater, Joseph L., David Osoba, Benny Zee, et al.. (1998). Effects of altering the time of administration and the time frame of quality of life assessments in clinical trials: an example using the EORTC QLQ-C30 in a large anti-emetic trial.. Quality of Life Research. 7(3). 273–278. 30 indexed citations
4.
Pater, Joseph L., W. Lofters, Benny Zee, et al.. (1997). The role of the 5-HT3 antagonists ondansetron and dolasetron in the control of delayed onset nausea and vomiting in patients receiving moderately emetogenic chemotherapy. Annals of Oncology. 8(2). 181–185. 54 indexed citations
6.
Cripps, M. Christine, Jacques Jolivet, W. Lofters, et al.. (1997). Phase II study of a multi-targeted antifolate (LY231514) (MTA) as first line therapy in patients with locally advanced or metastatic colorectal cancer (MCC). European Journal of Cancer. 33. S172–S172. 18 indexed citations
7.
Eisenhauer, Elizabeth A., F Letendre, W. Lofters, et al.. (1996). Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials Group.. Journal of Clinical Oncology. 14(2). 422–428. 137 indexed citations
10.
Rusthoven, James J., Joseph L. Pater, L Kaizer, et al.. (1991). A randomized, double-blinded study comparing six doses of batanopride (BMY-25801) with methylprednisolone in patients receiving moderately emetogenic chemotherapy. Annals of Oncology. 2(9). 681–686. 7 indexed citations
11.
Warr, David, Andrew R. Willan, Shai Fine, et al.. (1991). Superiority of Granisetron to Dexamethasone Plus Prochlorperazine in the Prevention of Chemotherapy-Induced Emesis. JNCI Journal of the National Cancer Institute. 83(16). 1169–1173. 41 indexed citations
12.
Murphy, Edward L., B Hanchard, J. Peter Figueroa, et al.. (1989). Modelling the risk of adult T‐cell leukemia/lymphoma in persons infected with human T‐lymphotropic virus type I. International Journal of Cancer. 43(2). 250–253. 320 indexed citations
13.
Clark, Jeffrey W., Corrado Gurgo, Genoveffa Franchini, et al.. (1988). Molecular epidemiology of HTLV-I-Associated non-Hodgkin's lymphomas in Jamaica. Cancer. 61(7). 1477–1482. 10 indexed citations
14.
Lofters, W., et al.. (1987). 2′-deoxycoformycin therapy in adult T-cell leukemia/lymphoma. Cancer. 60(11). 2605–2608. 37 indexed citations
15.
Clark, Jeffrey W., William A. Blattner, Carl Saxinger, et al.. (1985). Seroepidemiologic Studies Of Human T‐cell leukemia/lymphoma virus type I in Jamaica. International Journal of Cancer. 36(1). 37–41. 59 indexed citations
16.
Whang‐Peng, J., Bunn Pa, Turid Knutsen, et al.. (1985). Cytogenetic Studies in Human T-cell Lymphoma Virus (HTLV)-Positive Leukemia-Lymphoma in the United States. JNCI Journal of the National Cancer Institute. 74(2). 357–69. 38 indexed citations
17.
Gibbs, W. N., W. Lofters, B Hanchard, et al.. (1984). Adult T-cell leukemia/lymphoma in Jamaica and its relationship to human T-cell leukemia/lymphoma virus type I-associated lymphoproliferative disease.. PubMed. 15. 77–90. 6 indexed citations
18.
Campbell, M. A., et al.. (1978). Paroxysmal nocturnal haemoglobinuria in Jamaica.. PubMed. 27(3). 180–8. 1 indexed citations
19.
Lofters, W., Mahmoud Ali, & Graham F. Pineo. (1978). Preleukaemia and Reticulocytosis: A Case Report with in Vitro Evidence for Abnormal Reticulocyte Maturation. Scandinavian Journal of Haematology. 20(5). 417–422. 9 indexed citations
20.
Lofters, W., et al.. (1973). Henoch-Schönlein purpura occurring in three members of a family.. PubMed. 109(1). 46–8. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026